'In the study, three participants received autologous OTQ923 after myeloablative conditioning and were followed for 6 to 18 months. At the end of the follow-up period, all the participants had engraftment and stable induction of fetal hemoglobin'

https://www.nejm.org/doi/full/10.1056/NEJMoa2215643?query=featured_home